Axogen plans to process only human nerve tissue for Avance and other products at the new facility, which is being built to cGMP standards, and is intended to support a future Biologics License Application (BLA) for Avance Nerve Graft to the FDA . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge